P-230 - Aryliodonium ylides as efficient precursors for astatine-211 labeling - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Conference Papers Year :

P-230 - Aryliodonium ylides as efficient precursors for astatine-211 labeling

Clémence Maingueneau
  • Function : Author
Nuclear Oncology
Marion Berdal
  • Function : Author
Nuclear Oncology
Romain Eychenne
  • Function : Author
Nuclear Oncology
GIP ARRONAX [Nantes]
Joëlle Gaschet
  • Function : Author
Nuclear Oncology
Michel Chérel
  • Function : Author
Nuclear Oncology
Jean-Francois Gestin
  • Function : Author
Nuclear Oncology
Francois Guérard
Connectez-vous pour contacter l'auteur
Nuclear Oncology

Domains

Life Sciences [q-bio]
Fichier principal
Vignette du fichier
Maingueneau et al. - 2022 - P-230 - Aryliodonium ylides as efficient precursor.pdf (255.12 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

François Guérard  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-03842392

Submitted on : Monday, November 7, 2022-3:14:52 PM

Last modification on : Wednesday, May 24, 2023-4:13:52 PM

Long-term archiving on: Thursday, February 9, 2023-10:00:07 AM

Download

Dates and versions

inserm-03842392 , version 1 (07-11-2022)

Identifiers

  • HAL Id : inserm-03842392 , version 1

Cite

Clémence Maingueneau, Marion Berdal, Romain Eychenne, Joëlle Gaschet, Michel Chérel, et al.. P-230 - Aryliodonium ylides as efficient precursors for astatine-211 labeling. International symposium of radiopharmaceutical sciences, May 2022, Nantes, France. ⟨inserm-03842392⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM CNRS UNIV-ANGERS CRCI2NA NANTES-UNIVERSITE UFR-MEDECINE-NANTES
4 View
16 Download

Share

Gmail Facebook Twitter LinkedIn More